We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Gene Found for Common Form of Epilepsy

By LabMedica International staff writers
Posted on 18 Apr 2013
Print article
A gene mutation linked to the most common form of epilepsy has been found that could in the future lead to a genetic test for the condition.

The use of exome sequencing detected the gene for autosomal dominant familial focal epilepsy with variable foci (FFEVF) which is notable because family members have seizures originating from different cortical regions.

A team of scientists working with those at University of South Australia (Adelaide, SA, Australia) studied about 90 families where two members had epilepsy. The exomes of individuals were independently sequenced both in Australia and in The Netherlands. The coding sequences were enriched using the SureSelect Human All Exon 50Mb kit (Agilent Technologies; Santa Clara, CA, USA). After sequence capture and amplification, fragments were sequenced using a SOLiD v4 instrument (Applied Biosystems; Mulgrave, VIC, Australia).

The results showed that a gene called DEP domain-containing 5 (DEPDC5) causes focal epilepsy in about 12% of families in which only two people have focal epilepsy. This high frequency establishes DEPDC5 mutations as a common cause of familial focal epilepsies. As well as opening new opportunities for diagnosing epilepsy, the scientists believe their discovery will also lead to better targeted treatments.

The identification of DEPDC5 as the gene underlying FFEVF substantially advances understanding of the pathogenesis of epilepsy by implicating another new gene pathway. Apart from enabling the diagnosis of FFEVF through molecular testing, these findings also enable strategies to be devised to improve prognosis through tailored treatment targeting DEPDC5.

Ingrid E. Scheffer, MD, professor and pediatric neurologist, of the Florey Neuroscience Institute (Melbourne, VIC, Australia) said, "This discovery is paradigm shifting, if you have focal epilepsy and there is no cause known, then this gene should be tested to look for a mutation." The study was published on March 31, 2013, in the journal Nature Genetics.

Related Links:
University of South Australia
Agilent Technologies
Applied Biosystems


New
Gold Member
Thyroid Stimulating Hormone Assay
TSH EIA 96 Test
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
New
Four-in-One Desktop Testing Solution
GULP-1sim/GULP-1ble
New
Bordetella Pertussis ELISA
NovaLisa Bordetella Pertussis IgA

Print article

Channels

Clinical Chemistry

view channel
Image: The new saliva-based test for heart failure measures two biomarkers in about 15 minutes (Photo courtesy of Trey Pittman)

POC Saliva Testing Device Predicts Heart Failure in 15 Minutes

Heart failure is a serious condition where the heart muscle is unable to pump sufficient oxygen-rich blood throughout the body. It ranks as a major cause of death globally and is particularly fatal for... Read more

Hematology

view channel
Image: The discovery of a new blood group has solved a 50- year-old mystery (Photo courtesy of 123RF)

Newly Discovered Blood Group System to Help Identify and Treat Rare Patients

The AnWj blood group antigen, a surface marker discovered in 1972, has remained a mystery regarding its genetic origin—until now. The most common cause of being AnWj-negative is linked to hematological... Read more

Microbiology

view channel
Image: The inbiome molecular culture ID technology has received FDA breakthrough device designation (Photo courtesy of inbiome)

Revolutionary Molecular Culture ID Technology to Transform Bacterial Diagnostics

Bacterial infections pose a major threat to public health, contributing to one in five deaths worldwide. Current diagnostic methods often take several days to provide results, which can delay appropriate... Read more

Pathology

view channel
Image: Confocal- & laminar flow-based detection scheme of intact virus particles, one at a time (Photo courtesy of Paz Drori)

Breakthrough Virus Detection Technology Combines Confocal Fluorescence Microscopy with Microfluidic Laminar Flow

Current virus detection often relies on polymerase chain reaction (PCR), which, while highly accurate, can be slow, labor-intensive, and requires specialized lab equipment. Antigen-based tests provide... Read more

Industry

view channel
Image: The GeneXpert system’s fast PCR Xpert tests can fight AMR and superbugs with fast and accurate PCR in one hour (Photo courtesy of Cepheid)

Cepheid Partners with Fleming Initiative to Fight Antimicrobial Resistance

Antimicrobial resistance (AMR) is responsible for over one million deaths globally each year and poses a growing challenge in treating major infectious diseases like tuberculosis, Escherichia coli (E.... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.